SurveyMonkey, the world's most popular platform for surveys and forms, today announced it has been named a Leader in several Spring 2025 reports by G2, the world's largest and most trusted software ...

Maze Therapeutics IPOs at $487M, targeting APOL1 Kidney Disease with MZE829 in Phase 2. Click here to read an analysis of MAZE stock now.

Glioblastoma multiforme (GBM), commonly referred to as glioblastoma, is a malignant intracranial tumor derived from glial ...

Appdome, the leader in protecting mobile businesses, today revealed it has been recognized as the market leader and high performer in four (4) additional categories for Spring 2025 on G2, the world's ...

RBH has regained a compliant governance status after engaging with the English regulator over issues related to the death of ...

"Zentalis reported significant progress in the development of azenosertib in 2024 and made important advancements this year. We plan to maintain strong execution on the late-stage development of ...

A panel of Brazil Supreme Court justices unanimously ruled that former President Jair Bolsonaro and seven of his associates ...

Built with flexibility in mind, the ET G2 comes equipped with 200% DC oversizing, 98.2% efficiency, and an inbuilt smart ...

Nintendo is reportedly planning a three-phase launch for the Switch 2, with the first wave focusing on first-party titles. The Switch 2 could potentially launch in June, and rumors hint at new ...